Just 20% of firms with 200 or more workers said they covered GLP-1 drugs for weight loss, according to the Peterson-KFF Health System Tracker.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The US government designed a program to incentivize the development of treatments for rare tropical diseases. Big Pharma had other plans.